Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy
Keyword(s):
2014 ◽
Keyword(s):
2015 ◽
Vol 58
(9)
◽
pp. 4073-4079
◽
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 179
(3)
◽
pp. 615-629
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 102
◽
pp. 362-372
◽
Keyword(s):